Show pageBacklinksCite current pageExport to PDFBack to top This page is read only. You can view the source, but not change it. Ask your administrator if you think this is wrong. ====== Radiology Journal ====== ---- **Journal Title:** ''Radiology'' **Publisher:** Radiological Society of North America (RSNA) **Impact Factor (2023):** ~30 **Focus:** Diagnostic and interventional radiology, imaging science, AI, imaging biomarkers **Audience:** Radiologists, imaging scientists, medical physicists, clinicians, health policy experts ---- ===== 🔍 Scientific Rigor and Editorial Quality ===== * **✅ Strengths:** * Exceptional editorial standards, robust peer review, and statistical oversight. * Methodological transparency with frequent use of reporting guidelines (CONSORT, STARD, PRISMA). * External statistical reviews, especially for AI/quantitative studies. * **❌ Weaknesses:** * Tendency toward "impact factor inflation" and multicenter glamour over practical applicability. * Prioritization of high-tech imaging over clinically grounded investigations. ---- ===== 🧪 Clinical and Scientific Relevance ===== * **✅ Highlights:** * Influential studies on imaging guidelines, disease stratification, and emerging technologies. * Solid coverage of COVID-19, oncology, and stroke imaging. * **❌ Limitations:** * Many studies are retrospective, industry-funded, or from elite centers—limiting real-world translation. * Sparse analysis of cost-effectiveness, radiation burden, or long-term outcomes. ---- ===== 🤖 Artificial Intelligence and Methodological Integrity ===== * **✅ Positive Aspects:** * Leadership in AI publication and validation. * Promotes reproducibility via data/code sharing. * **❌ Concerns:** * Lack of true external validation in many AI articles. * Dataset bias, overfitting, and clinical integration gaps often underreported. ---- ===== 🌍 Diversity and Global Accessibility ===== * **✅ Progress:** * Hybrid open access model available. * Some global consortia represented. * **❌ Issues:** * High publication fees restrict accessibility. * Editorial board and authorship remain Western-dominated. * Underrepresentation of patient-centered and equity-driven research. ---- ===== 📊 Innovation vs. Hype ===== * **✅ Advances:** * Cutting-edge work in radiogenomics, hybrid modalities, perfusion imaging. * **❌ Pitfalls:** * Risk of technophilia: shiny methods with minimal discussion of healthcare integration. ---- ===== 📉 Ethics and Conflicts of Interest ===== * **✅ Practices:** * Transparent COI disclosures. * **❌ Problems:** * Industry sponsorship frequent. * Blurred lines between scientific content and promotional interest in some editorials. ---- ===== 🧾 Summary Verdict ===== ^ Category ^ Score (out of 5) ^ Comment ^ | Editorial and Statistical Rigor | ⭐⭐⭐⭐⭐ | Top-tier scientific control | | Clinical Utility | ⭐⭐⭐ | Needs better real-world translation | | AI and Quantitative Imaging | ⭐⭐⭐⭐ | Leading field with some gaps | | Global Representation | ⭐⭐ | Still US/Europe-centric | | Innovation vs. Practicality | ⭐⭐⭐ | Tech-focused but often impractical | | Conflict of Interest Handling | ⭐⭐⭐ | Transparent but vulnerable to industry | ---- ===== 📌 Bottom Line ===== > ''Radiology'' remains **the flagship journal** of imaging science—essential for scientific leadership. However, its **focus on prestige and high-tech trends** may eclipse critical issues in **clinical utility, health equity, and cost-conscious care**. radiology_journal.txt Last modified: 2025/06/25 06:58by administrador